Enteric coated risedronate 35mg for the treatment of osteoporosis

Description

In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Daryl Efron

A/Prof Daryl Efron

Autism Spectrum Disorder – Managing Challenging Behaviours

Dr Sam Mehr

Dr Sam Mehr

Paediatric Allergic Rhinitis & Immunotherapy

Prof Rodney Baber AM

Prof Rodney Baber AM

Premature Ovarian Insufficiency – The New Guidelines

Dr Richard Bradlow

Dr Richard Bradlow

Alcohol Addiction Assessment and Advice

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Ego Seeman

expert

Prof Ego Seeman

Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis

Date published: 7 November 2023